Terms: = Gastric cancer AND DDR2, NTRKR3, 4921, ENSG00000162733, Q16832, MIG20a, TYRO10
8 results:
1. Discovery of novel (E)-1-methyl-9-(3-methylbenzylidene)-6,7,8,9-tetrahydropyrazolo[3,4-d]pyrido[1,2-a]pyrimidin-4(1H)-one as ddr2 kinase inhibitor: Synthesis, molecular docking, and anticancer properties.
Ruzi Z; Bozorov K; Nie L; Zhao J; Akber Aisa H
Bioorg Chem; 2023 Jun; 135():106506. PubMed ID: 37030105
[TBL] [Abstract] [Full Text] [Related]
2. miR-199a-3p promotes gastric cancer progression by promoting its stemness potential via ddr2 mediation.
Ren L; Ren Q; Wang J; He Y; Deng H; Wang X; Liu C
Cell Signal; 2023 Jun; 106():110636. PubMed ID: 36813149
[TBL] [Abstract] [Full Text] [Related]
3. Further prognostic stratification of intestinal type of gastric adenocarcinoma by CDX2 expression pattern.
Hao Y; Liu BL; Liang Y; Xiong Y; Polydorides AD; Ward S
Hum Pathol; 2023 Jan; 131():61-67. PubMed ID: 36403867
[TBL] [Abstract] [Full Text] [Related]
4. Incidence and risk of cardiotoxicity in cancer patients treated with targeted therapies.
Santoni M; Guerra F; Conti A; Lucarelli A; Rinaldi S; Belvederesi L; Capucci A; Berardi R
Cancer Treat Rev; 2017 Sep; 59():123-131. PubMed ID: 28818671
[TBL] [Abstract] [Full Text] [Related]
5. ddr2 Expression Is Associated with a High Frequency of Peritoneal Dissemination and Poor Prognosis in Colorectal cancer.
Sasaki S; Ueda M; Iguchi T; Kaneko M; Nakayama H; Watanabe T; Sakamoto A; Mimori K
Anticancer Res; 2017 May; 37(5):2587-2591. PubMed ID: 28476831
[TBL] [Abstract] [Full Text] [Related]
6. ddr2 Induces gastric cancer Cell Activities via Activating mTORC2 Signaling and Is Associated with Clinicopathological Characteristics of gastric cancer.
Wang YG; Xu L; Jia RR; Wu Q; Wang T; Wei J; Ma JL; Shi M; Li ZS
Dig Dis Sci; 2016 Aug; 61(8):2272-2283. PubMed ID: 27010547
[TBL] [Abstract] [Full Text] [Related]
7. Integrated Molecular Profiling of Human gastric cancer Identifies ddr2 as a Potential Regulator of Peritoneal Dissemination.
Kurashige J; Hasegawa T; Niida A; Sugimachi K; Deng N; Mima K; Uchi R; Sawada G; Takahashi Y; Eguchi H; Inomata M; Kitano S; Fukagawa T; Sasako M; Sasaki H; Sasaki S; Mori M; Yanagihara K; Baba H; Miyano S; Tan P; Mimori K
Sci Rep; 2016 Mar; 6():22371. PubMed ID: 26934957
[TBL] [Abstract] [Full Text] [Related]
8. The intracellular juxtamembrane domain of discoidin domain receptor 2 (ddr2) is essential for receptor activation and ddr2-mediated cancer progression.
Kim D; Ko P; You E; Rhee S
Int J Cancer; 2014 Dec; 135(11):2547-57. PubMed ID: 24740739
[TBL] [Abstract] [Full Text] [Related]
